John Collison

speaker

6,048 appearances 22 recordings 1 series first heard Jun 2025 last heard 5 Feb

John Collison’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 10 in all, peaking in Oct 2025 with 5.

Appearances

newest first · ▶ plays the moment

Cheeky Pint · Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma · 11 Nov 2025 podcast

Large enterprises are creating better direct offerings than ever before with Stripe.

Learn more at Stripe.com/slash enterprise.

still the Ampex side.

new phenomenon where

My understanding, uh please correct me, is that uh, you know, traditionally you develop a molecule, you patent the molecule.

Now there's the growth of these clones where you can have the molecule be trivially different enough for patent purposes, but still the same action.

And there's a huge amount of that coming out of the Chinese biotech sector.

Doesn't that

that seems real and good and not.

Also real innovation.

That's an interesting one.

But but don't the clones effectively erode the patent system?

And you know, we would think shortening the patent life to fifteen years would be bad and or ten years, and this is shortening the patent life effectively.

So so was the shadow generic industry basically launched by First of File because we published the instruction manuals?

I didn't realize that.

is it your view if you just switch back?

Why?

GLPs obviously were initially researched, uh the initial RD was done for diabetes.

Yes.

Showing 1001–1020 of 6,048 · page 51 of 303